当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析

济川药业

(600566)

  

流通市值:229.62亿  总市值:230.44亿
流通股本:9.17亿   总股本:9.21亿

济川药业(600566)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润7.25亿元,每股收益0.78元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1353193.97万元,未分配利润898773.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1667603.53万元,负债314409.57万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,748,717,966.211,525,389,316.38,016,894,756.635,805,134,511.2
营业总成本2,042,988,755.571,106,091,598.545,388,666,480.383,879,965,357.38
其他经营收益
营业利润833,428,316.11502,324,358.52,862,889,616.442,119,657,580.92
利润总额849,042,833.53514,669,004.462,978,246,258.992,233,497,637.2
净利润725,285,908.9441,292,666.662,536,706,331.491,907,346,070.63
每股收益
其他综合收益----
综合收益总额725,285,908.9441,292,666.662,536,706,331.491,907,346,070.63
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计13,038,414,389.8514,637,024,658.9214,702,020,835.0414,349,997,698.34
非流动资产:
非流动资产合计3,637,620,941.83,696,472,919.443,757,473,071.423,801,778,486.46
资产总计16,676,035,331.6518,333,497,578.3618,459,493,906.4618,151,776,184.8
流动负债:
流动负债合计2,948,868,339.352,966,636,587.833,538,200,163.23,853,827,559.3
非流动负债:
非流动负债合计195,227,324.53199,563,460.58194,867,404.54202,812,952.7
负债合计3,144,095,663.883,166,200,048.413,733,067,567.744,056,640,512
所有者权益(或股东权益):
归属于母公司股东权益合计13,504,319,773.1115,141,767,178.414,701,852,74914,071,197,838.78
股东权益合计13,531,939,667.7715,167,297,529.9514,726,426,338.7214,095,135,672.8
负债和股东权益合计16,676,035,331.6518,333,497,578.3618,459,493,906.4618,151,776,184.8
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计3,989,642,612.472,682,585,478.499,721,019,491.227,739,228,359.6
经营活动现金流出小计3,017,168,261.141,888,681,002.717,544,582,475.445,999,715,661.26
经营活动产生的现金流量净额972,474,351.33793,904,475.782,176,437,015.781,739,512,698.34
投资活动产生的现金流量:
投资活动现金流入小计3,266,782,433.49917,852,231.985,119,418,9462,745,625,237.74
投资活动现金流出小计4,242,820,725.86927,049,337.567,159,335,473.354,822,222,826.31
投资活动产生的现金流量净额-976,038,292.37-9,197,105.58-2,039,916,527.35-2,076,597,588.57
筹资活动产生的现金流量:
筹资活动现金流入小计449,105,850.68283,631,958.411,441,663,600.751,159,785,934.41
筹资活动现金流出小计2,368,488,154.1322,581,170.932,646,804,155.552,037,620,537.42
筹资活动产生的现金流量净额-1,919,382,303.42-38,949,212.52-1,205,140,554.8-877,834,603.01
汇率变动对现金及现金等价物的影响103.35---
现金及现金等价物净增加额-1,922,946,141.11745,758,157.68-1,068,620,066.37-1,214,919,493.24
期末现金及现金等价物余额4,746,416,602.67,415,120,901.396,669,362,743.716,523,063,316.84
补充资料:
现金及现金等价物的净增加额-1,922,946,141.11--1,068,620,066.37-
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
浙商证券丁健行,吴天昊1.962.162.512025-08-29
国联民生郑薇1.792.002.232025-08-28
华安证券谭国超1.782.002.302025-08-27
中泰证券孙宇瑶,祝嘉琦2.002.212.422025-08-27
东吴证券朱国广1.721.942.192025-08-26
TOP↑